Insulin resistance, heart disease and inflammation. Identifying the 'at-risk' patient: the earlier the better? The role of inflammatory markers.
Koenig
Wolfgang
W
University of Ulm Medical Center, Germany.
D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000032:analysis; D003324:Coronary Artery Disease / Q000276:immunology* / Q000517:prevention & control; D016207:Cytokines / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000276:immunology; D004730:Endothelium, Vascular / Q000276:immunology*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance / Q000276:immunology*; D008264:Macrophages / Q000276:immunology; D009205:Myocarditis / Q000276:immunology*; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D013601:T-Lymphocytes / Q000276:immunology
D015415:Biomarkers; D016207:Cytokines; D000960:Hypolipidemic Agents; D002097:C-Reactive Protein